# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-059536
Filing Date
2024-07-05
Accepted
2024-07-05 16:01:06
Documents
10
Period of Report
2024-08-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea0208996-def14a_aditxt.htm | DEF 14A | 1711901
2 | GRAPHIC | image_001.jpg | GRAPHIC | 2835
3 | GRAPHIC | image_002.jpg | GRAPHIC | 9605
4 | GRAPHIC | image_003.jpg | GRAPHIC | 2696
5 | GRAPHIC | image_004.jpg | GRAPHIC | 2603
6 | GRAPHIC | image_005.jpg | GRAPHIC | 1941
7 | GRAPHIC | image_006.jpg | GRAPHIC | 2820
8 | GRAPHIC | image_007.jpg | GRAPHIC | 2823
9 | GRAPHIC | image_008.jpg | GRAPHIC | 584203
10 | GRAPHIC | image_009.jpg | GRAPHIC | 338689
| Complete submission text file | 0001213900-24-059536.txt |  | 3020114

Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39336 | Film No.: 241102608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)